EXHIBIT 5.1
                                                                     -----------

                              [Genesys Letterhead]

                               May 3, 2001

Genesys S.A.
Le Regent - 4 rue Jules Ferry
34008 Montpellier, France

Dear Sirs:

     I am the General Counsel of Genesys S.A., a French corporation ("Genesys").
I am familiar with the registration statement on Form S-8 covering ordinary
shares, par value EUR5 per share, of Genesys, to be issued in exchange for
shares of Vialog Corporation ("Vialog") deliverable upon exercise of Vialog
stock options, in connection with the merger of a wholly-owned subsidiary of
Genesys with Vialog, pursuant to the Merger Agreement dated October 1, 2000
between Genesys and Vialog (the "Merger Agreement").

     I am of the opinion that the ordinary shares of Genesys to be issued in
exchange for shares of Vialog common stock deliverable in respect of the Vialog
stock options as provided in the Merger Agreement (the "New Shares"), when
issued in accordance with the Merger Agreement, will be duly and validly issued,
fully paid and nonassessable.

     My opinion is based on the following interpretation of French law.

     I believe that the exchange of the New Shares for Vialog Common Stock
pursuant to the Merger Agreement amounts substantially to "une offre publique
d'echange" for the purpose of Article L.225-148 of the French Commercial Code
(the "Code"), for the reasons summarized below.

     (i)   An "offre publique d'echange" for the purpose of Article L.225-148 of
           the Code is not limited to (x) an "offre publique d'echange" as
           defined by the rules of the Reglement General du Conseil des Marches
           Financiers, since these rules only apply to offers made on French
           companies, or (y) a public exchange offer within the meaning of the
           U.S. Securities Act of 1933;

     (ii)  The exchange of shares to be consummated through the Merger is
           different from any procedure available under French law and, in
           particular, is different from a "fusion" within the meaning of
           article 1844-4 of the French Civil Code and Article L.236-1 of the
           Code, in that both Genesys and Vialog will survive the Merger; and

     (iii) The Merger has the characteristics of an "offre publique d'echange"
           for the purpose of Article L.225-148 of the code, as :

           a)   it amounts to an exchange of shares, proposed to public
                shareholders in the United States through a procedure which is
                under the control of U.S. stock
                exchange authorities and governed by U.S. securities laws and
                regulations; and

           b)   it is comparable in its consequences, calendar and disclosure
                obligations to a public exchange offer, and either procedure
                could have been used by Genesys.

     I believe that there are strong grounds to support this interpretation, but
I cannot predict whether a court of competent jurisdiction in the Republic of
France or elsewhere would support this interpretation in any judicial proceeding
on this question.

     I hereby consent to the reference to me under "Legal Matters" in such
registration statement.

                                         Very truly yours,


                                        /s/ Marie Capela-Laborde
                                        ------------------------
                                            Marie Capela-Laborde
                                            General Counsel